Results for “Regeneron”

…ng drugs called statins. It might be a big step in the battle against heart disease — and the approval is a triumph for Regeneron Pharmaceuticals, the Tarrytown, N.Y.-based biotechnology company that invented it. Praluent is likely to be more widely used, and to cost more, than W...

…ng drugs called statins. It might be a big step in the battle against heart disease — and the approval is a triumph for Regeneron Pharmaceuticals, the Tarrytown, N.Y.-based biotechnology company that invented it. Praluent is likely to be more widely used, and to cost more, than W...

…of-pocket costs to patients will vary depending on insurance status and eligibility for patient assistance. Sanofi and Regeneron are committed to ensuring that patients in the U.S. who are prescribed Praluent are able to access the medicine and receive the support they may need....

…like those who’ve had heart attacks or strokes, who are already taking the maximum dose of a statin they can tolerate. Regeneron and its marketing partner Sanofi say Praluent will have a wholesale cost of $40 a day, or $14,600 a year, for either of two doses, 75 milligrams or 15...

Regeneron. ""Praluent represents the culmination of more than a decade of tireless work to translate the

doctors expressed a preference for Praluent. One advantage of Regeneron’s drug is that doctors

…g drugs called statins. It might be a big step in the battle against heart disease — and the approval is a triumph for Regeneron Pharmaceuticals, the Tarrytown, N.Y.-based biotechnology company that invented it. Praluent is likely to be more widely used, and to cost more, than W...

because Amgen and Regeneron will compete by giving the insurers rebates.

… Dividends.Capital Gain $5,001 - $15,000 7 8 9 IO 11 GILEAD SCIENCES INC JPMORGAN CHASE & CO COM PHILIP MORRIS INTL INC REGENERON PHARMACEUTICALS UNITED PARCEL SERVICE INC CL B NIA None (or less than $1 ,001) Capital Gain $100,001 - $1 ,000,000 NIA None (or less than $1,001) Divi...

…ass A Consumer Discretionary Media 0% 445.3 DVN Devon Energy Corporation Energy Oil Gas & Consumable Fuels 8% 58.3 REGN Regeneron Pharmaceuticals, Inc. Health Care Biotechnology 0% 443 coG Cabot Oil & Gas Corporation Energy Oil Gas & Consumable Fuels 0% 43.5 EOG EOG Resources, In...